Latest Schedule 13G passive stakes

Alyeska Investment Group, L.P. and its affiliates have reported a beneficial ownership of 6.74% in Globant S.A. common shares as of June 30, 2026.

RA Capital Management, along with affiliated entities and individuals, has reported beneficial ownership of 3,483,099 shares, representing 6.3% of Avalo Therapeutics, Inc.'s common stock.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 5,475,040 shares, representing 8.22% of Fulcrum Therapeutics, Inc.'s common stock as of June 30, 2026.

RA Capital Management and its affiliates report maintaining a 9.9% beneficial ownership in Adicet Bio, Inc. as of June 30, 2026, primarily through RA Capital Healthcare Fund, L.P.

Alyeska Investment Group, L.P., along with its affiliates, has reported beneficial ownership of 5.08% of Forward Industries, Inc. common stock, acquiring shares through a private placement and pre-funded warrants.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has disclosed beneficial ownership of 400,000 shares, representing 9.91% of Eloxx Pharmaceuticals' common stock as of June 30, 2026.

Fourthstone LLC and affiliated entities have updated their beneficial ownership filing for Eagle Financial Services Inc., reporting a combined 5.31% stake.

Lightspeed Venture Partners has filed a Schedule 13G, detailing their beneficial ownership of Rubrik, Inc. Class A common stock as of June 30, 2026.

Nantahala Capital Management, LLC, along with its principals Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 9.99% of Azitra, Inc.'s common stock as of June 30, 2026.

RA Capital Management, along with affiliated entities and individuals, has reported a beneficial ownership of 9.1% of Aclaris Therapeutics' common stock as of June 30, 2026.

Several Lightspeed Venture Partners entities have filed a Schedule 13G, detailing their collective beneficial ownership of Netskope, Inc. Class A common stock as of June 30, 2026.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 9.69% of ADC Therapeutics SA's common shares as of June 30, 2026.

First Light Asset Management, LLC and Mathew P. Arens report increased beneficial ownership of Axogen, Inc. common stock, now holding approximately 7.58%.

Lynx1 Capital Management LP and Weston Nichols have reported beneficial ownership of 13.1% of TScan Therapeutics, Inc. common stock as of June 30, 2026.

Platinum Equity entities and Tom Gores have collectively adjusted their beneficial ownership of Ryerson Holding Corporation's common stock to 3.7%, reporting shared voting and dispositive power over 1,924,478 shares.

Several KKR-affiliated entities and individuals have filed a joint Schedule 13G statement, disclosing beneficial ownership of over 81% of GMR Solutions Inc.'s Class A common stock.

Disciplined Growth Investors Inc. has updated its Schedule 13G filing to reflect its beneficial ownership of Powerfleet, Inc. common stock.

Austin Meyer has increased his beneficial ownership of BETA Technologies' Class A Common Stock to 5.4%, holding over 12 million shares.

Lynx1 Capital Management LP and Weston Nichols have disclosed a beneficial ownership of 13,263,288 ordinary shares, representing 19.3% of GH Research PLC.

CB Elevate Aggregator L.P. and affiliated entities report beneficial ownership of 3,178,251 shares of Forbright Inc. Class A common stock, representing 9.9% of the outstanding shares.

Crosslink Capital, Inc. and Michael J. Stark have jointly filed a Schedule 13G, reporting beneficial ownership of 5.7% of i3 Verticals, Inc. Class A Common Stock as of June 30, 2026.

Divisadero Street Capital Management, LP and affiliated entities have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Rush Street Interactive, Inc. Class A common stock.

Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh have jointly filed a Schedule 13G, reporting beneficial ownership of 500,000 shares, or 3.90%, of Dragonfly Energy Holdings Corp. common stock as of June 30, 2026.

Fourthstone LLC and affiliated entities have filed a Schedule 13G, reporting a 0.00% beneficial ownership of Carter Bankshares, Inc. common stock.

TCG Crossover entities have updated their Schedule 13G filing, reporting beneficial ownership of Vistagen Therapeutics' common stock, primarily through exercisable warrants.

Fourthstone LLC and affiliated entities have reported beneficial ownership of 7.36% of Bank of the James Financial Group Inc. common stock, acquired in the ordinary course of business.

A significant stakeholder group, including Stoney Lonesome HF LP and Coghill Capital Management LLC, has updated its beneficial ownership filing for Health Catalyst, Inc., reporting a combined 9.6% stake.

Montanova Capital, Averill Master Fund, and Aaron Cowen have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Kura Oncology, Inc. common stock.

Alyeska Investment Group, L.P., along with affiliated entities, has disclosed a beneficial ownership of 1.16% in SkyX Platforms Corp. common stock.

Fourthstone LLC and affiliated entities have filed an amendment to their Schedule 13G, reporting changes in beneficial ownership of Avidbank Holdings, Inc. common stock.